3322

US

Hig

hway

22

Sui

te 4

08B

ranc

hbur

g, N

J 08

876

Supported by an educational grant from

Salix, a Division of Valeant Pharmaceuticals North America

Jointly provided by Center for Independent Healthcare Education and Vemco MedEd

THE PHARMACIST’S ROLE IN PREVENTION & MANAGEMENT OF OPIOID-INDUCED CONSTIPATION

Utilizing Proactive Approaches

Facu

lty

Reg

ister

Onl

ine

Toda

y!

A Satellite Symposium held in conjunction with APhA 2016

Saturday, March 5, 2016 6:00 – 6:30 AM Registration & Breakfast 6:30 – 8:00 AM Educational Program

Hilton Baltimore 401 West Pratt Street Holiday Ballroom 6

THE

PH

ARM

ACIS

T’S

RO

LE IN

PREV

ENTI

ON

& M

AN

AG

EMEN

T O

F O

PIO

ID-I

ND

UCED

CO

NST

IPA

TIO

N

Util

izin

gPro

activ

e A

ppro

ache

s

Gre

gory

L.

Holm

quis

t, P

harm

D,

CP

E

Pai

n an

d P

allia

tive

Car

e S

pec

ialis

t C

ertifi

ed P

ain

Ed

ucat

or

Pal

liativ

e C

are

Str

ateg

ies

Sea

ttle

, WA

ww

ww

.vem

com

eded

.com

(s

elec

t “R

egis

ter

for

Pro

gra

ms”

)

Opioids are increasingly prescribed to treat chronic cancer and noncancer pain. Opioid-induced constipation (OIC) is one of the most common and troublesome adverse events associated with opioids, impacting the majority of patients being treated for chronic pain. In addition to the clinical consequences, OIC is also associated with diminished quality of life, compromised pain management, and increased use of healthcare resources. For many, laxatives remain the treatment of choice in preventing and managing OIC, but these agents are associated with significant limitations and risks. More recent advancements have led to the development of a more targeted approach that specifically counteracts the effects of opioids in the gastrointestinal tract. As the role of pharmacists in managing patients with chronic pain grows within the multidisciplinary team, it is imperative that pharmacists improve their competence in the prevention and treatment of OIC. This can include utilizing effective prevention strategies, recognizing the early signs of OIC, and selecting the optimal approach to treat OIC based on patient-specific factors. This program provides an overview of the burden and pathophysiology of OIC and offers practical solutions in the prevention and treatment of OIC through case-based discussions.

This continuing pharmacy education activity is planned to meet the needs of pharmacists in a variety of practice settings, including large and small healthcare systems, outpatient clinics, managed care organizations, long-term care facilities, community pharmacies, and academia. This program will target pharmacists who are involved in the management of patients with or at-risk for OIC.

Those attending the program will be able at its conclusion to:

• Discuss the impact of opioid medications on bowel function and recognize patients at risk for opioid-induced constipation (OIC)

• Utilize proactive approaches to prevent OIC among patients initiating or continuing to use opioid medication

• Evaluate the use of newer, non-laxative, pharmacotherapeutic agents in the management of OIC based on patient factors

Educational Overview

Target Audience

Learning ObjectivesAMERICANS WITH DISABILITIES ACTVemco MedEd and Center for Independent Healthcare Education fully comply with the Americans With Disabilities Act. Please submit a written request at least 5 days prior to the meeting, and we will be glad to assist you with any special needs required to make this program accessible to you. Please email your request to cme@vemcomeded.com.

DISCLOSURES OF CONFLICT OF INTERESTCenter for Independent Healthcare Education and Vemco MedEd require faculty, planners, and others who are in a position to control the content of continuing education activities to disclose to the audience any real or apparent conflict of interest related to the activity. All identified conflicts of interest are reviewed and resolved to ensure fair balance, objectivity, and scientific rigor in all activities. The faculty is further required to disclose discussion of off-label uses in their presentations.

ACCREDITATION STATEMENT  Pharmacists

Center for Independent Healthcare Education is

accredited by the Accreditation Council for Pharmacy Education as a provider for continuing pharmacy education. Center has assigned 1.5 contact hours (0.15 CEUs) of continuing pharmacy education credits for participating in this activity.

ACPE UAN: 0473-9999-16-003-L01-P Activity type: Knowledge-based

Agenda6:00 – 6:30 AM Registration and Breakfast6:30 – 8:00 AM Educational Program

6:30 – 6:40 AM Opioid-Induced Constipation: Recognizing the Burden

6:40 – 7:50 AM Pathophysiology and Prevention of OIC Knowing the Treatment Options

7:50 – 8:00 AM Open Forum: Q and A

1. Please go to www.vemcomeded.com and select “Register for Programs”

2. Email your name, affiliation, and mailing address to CME@vemcomeded.com

3. Use a QR Code Reader on your mobile device to register online by scanning the image.

RegistrationThree easy ways to register:

There is no registration fee to attend this continuing education activity. Pre-registration is for planning purposes only and seating will be available on a first-come, first-served basis.